Covid Vaccine Makers Score Partial Wins in UK Patent Suit (1)

Moderna Inc. scored a partial victory in its attempt to claim a share of billions of dollars in profits made by Pfizer Inc and BioNTech SE selling Covid-19 vaccine, after a London judge ruled that one of its two patents was valid.

Pfizer and and its German partner for the vaccine BioNTech filed a UK lawsuit seeking to invalidate two patents behind Moderna’s vaccine, Spikevax, claiming they had no novelty. Moderna also sued seeking damages from Pfizer and BioNTech alleging their vaccine Comirnaty infringed its patent.

The two contentious patents behind the Covid-19 vaccine form part of a bitterly fought ...